Cargando…

IPO5 Mediates EMT and Promotes Esophageal Cancer Development through the RAS-ERK Pathway

OBJECTIVE: In the development of many tumors, IPO5, as a member of the nuclear transporter family, exerts a significant function. Also, IPO5 is used as a therapeutic target for tumors based on some reports. By studying IPO5 expression in esophageal cancer tissues, the mechanism associated with IPO5...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Meiyu, Li, Xiaofei, Chen, Shujia, Zhang, Tianai, Song, Liaoyuan, Pei, Jiayue, Sun, Guoyan, Guo, Lianyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481360/ https://www.ncbi.nlm.nih.gov/pubmed/36120598 http://dx.doi.org/10.1155/2022/6570879

Ejemplares similares

SERPINE1 Overexpression Promotes Malignant Progression and Poor Prognosis of Gastric Cancer
por: Chen, Shujia, et al.
Publicado: (2022)

Tspan9 Induces EMT and Promotes Osteosarcoma Metastasis via Activating FAK-Ras-ERK1/2 Pathway
por: Shao, Shijie, et al.
Publicado: (2022)

IPO7 promotes pancreatic cancer progression via regulating ERBB pathway
por: Li, Ming, et al.
Publicado: (2022)

High-profit IPO strategies: finding breakout IPOs for investors and traders
por: Taulli, Tom, et al.
Publicado: (2013)

Mulberry polyphenol extracts attenuated senescence through inhibition of Ras/ERK via promoting Ras degradation in VSMC
por: Chen, Ching-Pei, et al.
Publicado: (2022)

Tetraspanin 7 promotes osteosarcoma cell invasion and metastasis by inducing EMT and activating the FAK-Src-Ras-ERK1/2 signaling pathway
por: Shao, Shijie, et al.
Publicado: (2022)

Corporate governance in IPO firms
por: Lehmann, Erik E, et al.
Publicado: (2020)

RAS Dimers: The Novice Couple at the RAS-ERK Pathway Ball
por: Herrero, Ana, et al.
Publicado: (2021)

Trichostatin A promotes esophageal squamous cell carcinoma cell migration and EMT through BRD4/ERK1/2‐dependent pathway
por: Liu, Danhui, et al.
Publicado: (2021)

RDM1 promotes neuroblastoma growth through the RAS–Raf–MEK–ERK pathway
por: Xie, Guojin, et al.
Publicado: (2019)

Latent class analysis of IPOs in the Nordics
por: Bask, Mikael, et al.
Publicado: (2021)

EMT-Induced Stemness and Tumorigenicity Are Fueled by the EGFR/Ras Pathway
por: Voon, Dominic Chih-Cheng, et al.
Publicado: (2013)

Immune-Related lncRNA Pairs Clinical Prognosis Model Construction for Hepatocellular Carcinoma
por: Zhu, Yinghui, et al.
Publicado: (2022)

Correction: Latent class analysis of IPOs in the Nordics
Publicado: (2023)

COPS3 Promotes Proliferation, Invasion, and EMT of Colorectal Cancer Cells by MEK/ERK Pathway
por: Xie, Yanchao, et al.
Publicado: (2022)

Chronic stress model simulated by salbutamol promotes tumorigenesis of gastric cancer cells through β2-AR/ERK/EMT pathway
por: Lu, YanJie, et al.
Publicado: (2022)

Livin participates in resistance to trastuzumab therapy for breast cancer through ERK1/2 and AKT pathways and promotes EMT-like phenotype
por: Li, Fan, et al.
Publicado: (2018)

Regulation A+ and Other Alternatives to a Traditional IPO
por: Feldman, David
Publicado: (2018)

IPO: a tool for automated optimization of XCMS parameters
por: Libiseller, Gunnar, et al.
Publicado: (2015)

Unicorns’ growth and financial flexibility before and after the IPO
por: Zhou, Man, et al.
Publicado: (2023)

IPO5 promotes the proliferation and tumourigenicity of colorectal cancer cells by mediating RASAL2 nuclear transportation
por: Zhang, Wenjuan, et al.
Publicado: (2019)

HPIP is an essential scaffolding protein running through the EGFR-RAS-ERK pathway and drives tumorigenesis
por: Jiang, Qiwei, et al.
Publicado: (2023)

Effect of Ghrelin Intervention on the Ras/ERK Pathway in the Regulation of Heart Failure by PTEN
por: Zhao, Yong, et al.
Publicado: (2022)

Calreticulin promotes EGF-induced EMT in pancreatic cancer cells via Integrin/EGFR-ERK/MAPK signaling pathway
por: Sheng, Weiwei, et al.
Publicado: (2017)

Ras Post-transcriptionally Enhances a Pre-malignantly Primed EMT to Promote Invasion
por: Bisogno, Laura S., et al.
Publicado: (2018)

ABCA1-Mediated EMT Promotes Papillary Thyroid Cancer Malignancy through the ERK/Fra-1/ZEB1 Pathway
por: Park, Ji-Hye, et al.
Publicado: (2023)

The Ras/Raf/MEK/ERK signaling pathway and its role in the occurrence and development of HCC
por: Li, Lei, et al.
Publicado: (2016)

FGFR3 promotes the growth and malignancy of melanoma by influencing EMT and the phosphorylation of ERK, AKT, and EGFR
por: Li, Lei, et al.
Publicado: (2019)

Inhibition of colon cancer K-Ras(G13D) mutation reduces cancer cell proliferation but promotes stemness and inflammation via RAS/ERK pathway
por: Qi, Yan, et al.
Publicado: (2022)

COVID-19: Fear of pandemic and short-term IPO performance
por: Mazumder, Sharif, et al.
Publicado: (2021)

Nuclear Transporter IPO13 Is Central to Efficient Neuronal Differentiation
por: Gajewska, Katarzyna A., et al.
Publicado: (2022)

Competitive threat and strategic disclosure during the IPO quiet period
por: Qiu, Yetaotao, et al.
Publicado: (2022)

The Ras-Erk-ETS-Signaling Pathway Is a Drug Target for Longevity
por: Slack, Cathy, et al.
Publicado: (2015)

Polymorphisms in RAS/RAF/MEK/ERK Pathway Are Associated with Gastric Cancer
por: Gonzalez-Hormazabal, Patricio, et al.
Publicado: (2018)

Oncogenic mutant RAS signaling activity is rescaled by the ERK/MAPK pathway
por: Gillies, Taryn E, et al.
Publicado: (2020)

BRD2 induces drug resistance through activation of the RasGRP1/Ras/ERK signaling pathway in adult T‐cell lymphoblastic lymphoma
por: Tian, Xiao‐Peng, et al.
Publicado: (2020)

Hydrostatic pressure promotes endothelial tube formation through aquaporin 1 and Ras-ERK signaling
por: Yoshino, Daisuke, et al.
Publicado: (2020)

How to create the next Facebook: seeing your startup through, from idea to IPO
por: Taulli, Tom
Publicado: (2012)

FGF signaling controls caudal hindbrain specification through Ras-ERK1/2 pathway
por: Aragon, Ferran, et al.
Publicado: (2009)

AHSA1 Promotes Proliferation and EMT by Regulating ERK/CALD1 Axis in Hepatocellular Carcinoma
por: Zhang, Jiakang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_isl6tgvpqrf31vjef6777gdc48